Drug Shortage Report for AVAPRO
Report ID | 139795 |
Drug Identification Number | 02237924 |
Brand name | AVAPRO |
Common or Proper name | Avapro |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IRBESARTAN |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 90 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-05-21 |
Estimated end date | 2021-08-13 |
Actual end date | 2021-08-09 |
Shortage status | Resolved |
Updated date | 2021-08-11 |
Company comments | Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-08-11 | French | Compare |
v8 | 2021-08-11 | English | Compare |
v7 | 2021-07-26 | French | Compare |
v6 | 2021-07-26 | English | Compare |
v5 | 2021-06-18 | French | Compare |
v4 | 2021-06-18 | English | Compare |
v3 | 2021-05-22 | English | Compare |
v2 | 2021-05-21 | French | Compare |
v1 | 2021-05-21 | English | Compare |
Showing 1 to 9 of 9